🇫🇷
France · FR · FR:69537091
NINLARO 4 mg, gélule
ReimbursedATC L01XG
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerTAKEDA PHARMA (DANEMARK)
CountryFR (France)
ATC codeL01XG
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009300777263 plaquette(s) PVC aluminium de 1 gélule(s)EUR 3.36
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "69537091",
"date_amm": "2016-11-21",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/16/1094",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L01XG.
- 🇪🇸NINLARO 2,3 MG CAPSULAS DURASTakeda Pharma A/S
- 🇫🇷NINLARO 2,3 mg, géluleTAKEDA PHARMA (DANEMARK)
- 🇪🇸NINLARO 3 MG CAPSULAS DURASTakeda Pharma A/S
- 🇫🇷NINLARO 3 mg, géluleTAKEDA PHARMA (DANEMARK)
- 🇪🇸NINLARO 4 MG CAPSULAS DURASTakeda Pharma A/S
- 🇫🇷VELCADE 1 mg, poudre pour solution injectableJANSSEN CILAG INTERNATIONAL NV
- 🇪🇸VELCADE 3,5 mg, POLVO PARA SOLUCION INYECTABLEJanssen-Cilag International N.V
- 🇫🇷VELCADE 3,5 mg, poudre pour solution injectableJANSSEN CILAG INTERNATIONAL NV
Access this data programmatically
Query NINLARO 4 mg, gélule and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.